APTEVO THERAPEUTICS INC (APVO) Stock Analyst Earnings Estimates
NASDAQ:APVO - Nasdaq - US03835L4059 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.309M | 12.292M 185.26% | 3.114M -74.67% | -100.00% | 6.871M | 18.091M 163.30% | 34.583M 91.16% | 46.113M 33.34% | 55.168M 19.64% | 62.254M 12.84% | ||||
| EBITDA YoY % growth | -26.088M 32.64% | -20.256M 22.36% | -27.74M -36.95% | N/A -2.06% | N/A 12.94% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.494M 32.88% | -21.4M 22.16% | -28.641M -33.84% | -29.808M -0.83% | -23.907M 13.43% | -23.388M 6.45% | -23.764M -1.61% | -17.276M 27.30% | -6.446M 62.69% | 10.255M 259.08% | 21.987M 114.40% | 31.236M 42.07% | 38.511M 23.29% | |
| Operating Margin | -638.06% | -174.10% | -919.75% | N/A | N/A | N/A | N/A | -251.43% | -35.63% | 29.65% | 47.68% | 56.62% | 61.86% | |
| EPS YoY % growth | -291,737.60 43.86% | -198,290.40 32.03% | 51,444.80 125.94% | -56,957.21 -193.67% | -1,753.58 78.00% | -323.14 96.95% | -295.60 8.52% | -204.61 30.78% | -72.83 64.41% | 57.94 179.55% | 121.18 109.15% | 132.40 9.26% | 167.69 26.66% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -84.86 93.13% | -77.11 78.29% | -76.30 95.37% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.851M 2.81% | -5.843M -12.08% | -5.835M 8.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -87.80 98.81% | -85.88 | -1.92 | -2.23% |
| Q4 2024 Q2Q % growth | -1,647.40 63.86% | -158.10 | -1,489.30 | -942.00% |
| Q3 2024 Q2Q % growth | -355.20 97.82% | -2,532.35 | 2,177.15 | 85.97% |
| Q2 2024 Q2Q % growth | -1,235.80 96.91% | -4,943.94 | 3,708.14 | 75.00% |
| Q1 2024 Q2Q % growth | -7,363.00 -157.98% | -9,695.41 | 2,332.41 | 24.06% |
| Q4 2023 Q2Q % growth | -4,558.40 85.26% | -13,616.59 | 9,058.19 | 66.52% |
| Q3 2023 Q2Q % growth | -16,280.00 66.67% | -24,908.40 | 8,628.40 | 34.64% |
| Q2 2023 Q2Q % growth | -40,048.80 -122.04% | -37,196.54 | -2,852.26 | -7.67% |
| Q1 2023 Q2Q % growth | 12,698.40 125.16% | -39,355.27 | 52,053.67 | 132.27% |
| Q4 2022 Q2Q % growth | -30,932.00 25.20% | -50,813.14 | 19,881.14 | 39.13% |
| Q3 2022 Q2Q % growth | -48,840.00 -4.90% | -54,466.37 | 5,626.37 | 10.33% |
| Q2 2022 Q2Q % growth | 181,684.80 418.86% | -44,170.90 | 225,855.70 | 511.32% |
| Q1 2022 Q2Q % growth | -50,468.00 5.49% | -38,192.88 | -12,275.12 | -32.14% |
| Q4 2021 Q2Q % growth | -41,351.20 33.85% | -43,008.50 | 1,657.30 | 3.85% |
| Q3 2021 Q2Q % growth | -46,560.80 31.90% | -48,986.52 | 2,425.72 | 4.95% |
| Q2 2021 Q2Q % growth | -56,980.00 16.67% | -66,422.40 | 9,442.40 | 14.22% |
| Q1 2021 Q2Q % growth | -53,398.40 42.25% | 56,126.93 | -109,525.33 | -195.14% |
| Q4 2020 Q2Q % growth | -62,515.20 19.33% | -40,351.61 | -22,163.59 | -54.93% |
| Q3 2020 Q2Q % growth | -68,376.00 34.78% | -66,920.57 | -1,455.43 | -2.17% |
| Q2 2020 Q2Q % growth | -68,376.00 50.00% | -68,249.02 | -126.98 | -0.19% |
| Q1 2020 Q2Q % growth | -92,470.40 53.90% | -78,046.32 | -14,424.08 | -18.48% |
| Q4 2019 Q2Q % growth | -77,492.80 | -119,340.46 | 41,847.66 | 35.07% |
| Q3 2019 Q2Q % growth | -104,843.20 | -111,589.63 | 6,746.43 | 6.05% |
| Q2 2019 Q2Q % growth | -136,752.00 | -153,435.74 | 16,683.74 | 10.87% |
| Q1 2019 Q2Q % growth | -200,569.60 | -204,580.99 | 4,011.39 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | 3.494M | -3.494M | -100.00% |
| Q1 2022 Q2Q % growth | 3.114M 28.62% | 3.825M | -711K | -18.59% |
| Q4 2021 Q2Q % growth | 3.665M 54.45% | 3.468M | 197K | 5.68% |
| Q3 2021 Q2Q % growth | 3.096M 111.62% | 3.723M | -627K | -16.84% |
| Q2 2021 Q2Q % growth | 3.11M 557.51% | 918K | 2.192M | 238.78% |
| Q1 2021 Q2Q % growth | 2.421M | 13.328M | -10.907M | -81.84% |
| Q4 2020 Q2Q % growth | 2.373M | 1.78M | 593K | 33.31% |
| Q3 2020 Q2Q % growth | 1.463M | 574.943K | 888.057K | 154.46% |
| Q2 2020 Q2Q % growth | 473K | 266.903K | 206.097K | 77.22% |
| Q1 2020 Q2Q % growth | 5.272M | -5.272M | -100.00% | |
| Q4 2019 Q2Q % growth | 9.609M | -9.609M | -100.00% | |
| Q3 2019 Q2Q % growth | 9.18M | -9.18M | -100.00% | |
| Q2 2019 Q2Q % growth | 7.185M | -7.185M | -100.00% | |
| Q1 2019 Q2Q % growth | 6.903M | -6.903M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1900% | 0% | -1900% |
| Revenue | N/A | N/A | N/A | N/A |